Mo-Rez achieved confirmed objective response rates of 62% in patients with platinum-resistant ovarian cancer. Credit: MMD ...

Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers Data Anticipated in Late 2026 or Early 2027 SOUTH SAN FRANCISCO, Calif., ...

AbbVie is running a Phase III trial of Elahere in PSOC, Credit: Smith Collection/Gado/ AbbVie’s Elahere has shown a 62.7% objective response rate (ORR) in patients with platinum-sensitive ovarian ...

Trial met all primary and key secondary endpoints, including progression-free survival and overall survival Company intends ...

Revolution Medicines Inc. RVMD shares are up during Monday’s premarket session following positive topline results from its ...

AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...

April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a Phase II Clinical Trial of ...

Clinical trials are vital for developing safer, more effective metastatic breast cancer treatments, yet participation is low due to access and financial barriers. Trials progress through phases, from ...

Arvinas plans Phase 3 trials for vepdegestrant combinations in breast cancer and initiates trials for new Parkinson's disease treatments. Arvinas, Inc. announced its plans to begin two Phase 3 ...

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines ...

Clinical trials are an essential step in medical science; they are the key. They serve to answer questions about the safety and efficacy of new treatments, drugs, and interventions. In this post, we ...